• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

FDA-TRACK Archive

The list below provides information on FDA’s performance measures and projects as aligned to FDA strategic priorities and program offices. This list enables you to view charts of performance data and progress on important projects and programs.

To view current FDA-TRACK performance measures and projects view the Active Index

Filter








Results

Number of results: 15

ItemProgramOfficeFY
Completed
Strategic PlanStrategic Goal/Area
1Cumulative percent of CDRH staff and reviewers trained in new accessibility criteria at the end of the monthACAN/A2012N/AN/A
2Provide information to women and health care providers on those areas in which differences between men and women existACAN/A2013N/AN/A
3Women's Participation in Clinical TrialsACAN/A2011N/AN/A
4Establish an abbreviated regulatory review pathway for biosimilar and interchangeable biological productsACAN/A2012N/AN/A
5Number of outreach activities to generate awareness regarding the FDA's minority health activitiesACAN/A2011N/AN/A
6Number of Departmental meetings in the month related to ACA implementationACAN/A2013N/AN/A
7Cumulative number of visits to new FDA minority health webpage in the monthACAN/A2013N/AN/A
8Number of external FDA stakeholder meetings in the monthACAN/A2013N/AN/A
9Number of outreach activities to promote FDA advisory committee vacanciesACAN/A2011N/AN/A
10Number of inquiries by FDA Centers for Advisory Committee vacanciesACAN/A2011N/AN/A
11Ensure that the Office of Minority Health meets the requirements set out in the Affordable Care ActACAN/A2011N/AN/A
12Office of Minority Health Infrastructure DevelopmentACAN/A2011N/AN/A
13Strengthen FDA capacity to address minority health and health disparities across the AgencyACAN/A2013N/AN/A
14Strengthen Regulatory Science/Health Disparities Research InitiativesACAN/A2013N/AN/A
15Implement new ANDA labeling change provisionsACAN/A2011N/AN/A

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information in the Archive Index may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.